Kang P. Li
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
ZC3H13-mediated m6A stabilization of CCND1 promotes malignant progression and is associated with poor anti-PD-1 response in HNSCC.
Journal: Clinical and translational medicine
Published: March 24, 2026
The role of the tumor microenvironment in HNSCC resistance and targeted therapy.
Journal: Frontiers in immunology
Published: January 03, 2025
Autonomous driving system based on dual process theory and deliberate practice theory.
Journal: Nature communications
Published: January 01, 2025
PCIF1 drives oesophageal squamous cell carcinoma progression via m6Am-mediated suppression of MTF2 translation.
Journal: Clinical and translational medicine
Published: December 02, 2024
Selective removal of cesium ions from aqueous solution by different metal (Zn2+/Ni2+) hexacyanocobaltate.
Journal: Environmental research
Published: October 27, 2024
Matrix stiffness regulates NPC invasiveness by modulating a mechanoresponsive TRPV4-Nox4-IL-8 signaling axis.
Journal: Journal of Cancer
Published: September 26, 2024
Integrating machine learning, bioinformatics and experimental verification to identify a novel prognostic marker associated with tumor immune microenvironment in head and neck squamous carcinoma.
Journal: Frontiers in immunology
Published: September 25, 2024
Integrating bulk and single-cell sequencing data to construct a Scissor+ dendritic cells prognostic model for predicting prognosis and immune responses in ESCC.
Journal: Cancer immunology, immunotherapy : CII
Published: February 05, 2024
ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4+ macrophage infiltration.
Journal: Nature communications
Published: November 03, 2023
The CTBP2-PCIF1 complex regulates m6Am modification of mRNA in head and neck squamous cell carcinoma.
Journal: The Journal of clinical investigation
Published: March 01, 2023
CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer.
Journal: Nature communications
Published: February 07, 2023
Last Updated: 09/26/2026